SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : PFE (Pfizer) How high will it go? -- Ignore unavailable to you. Want to Upgrade?

To: John F. Dowd who wrote (7879)6/10/1999 8:08:00 PM
From: manny t  Read Replies (1) | Respond to of 9523
 
Pfizer is probably having a ball buying these shares for their

Buy Back program.This will definitely put a limit on the downside.

I myself bought more shares at 100 3/8.

I can't wait for the split on 6/30,to own 3 times as many shares at 33 1/2.

I LOVE A BARGAIN.
IMHO
Manny T.




To: John F. Dowd who wrote (7879)6/10/1999 11:37:00 PM
From: pkwknk  Read Replies (2) | Respond to of 9523
 
These analyst are penguins just like Kernan and Faber joke.



To: John F. Dowd who wrote (7879)6/11/1999 11:52:00 AM
From: Brian Malloy  Respond to of 9523
 
Rest assured, Trovan was not being used as a "last chance anti-biotic" and it was not marketed as a "last chance anti-biotic".


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News